{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:41:30Z","timestamp":1784864490105,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ajoc.2022.101607","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T02:17:52Z","timestamp":1654049872000},"page":"101607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Local recurrence of uveal melanoma and concomitant brain metastases associated with an activating telomerase promoter mutation seven years after secondary enucleation"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6291-6688","authenticated-orcid":false,"given":"Jacob S.","family":"Heng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany M.","family":"Perzia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Sinard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renelle","family":"Pointdujour-Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ajoc.2022.101607_bib1","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajoc.2022.101607_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes","volume":"127","author":"Shields","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajoc.2022.101607_bib3","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma","volume":"44","author":"Kujala","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajoc.2022.101607_bib4","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28","volume":"124","year":"2006","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101607_bib5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ophtha.2014.08.046","article-title":"Management of posterior uveal melanoma: past, present, and future: the 2014 charles L. Schepens lecture","volume":"122","author":"Shields","year":"2015","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101607_bib6","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archopht.119.5.670","article-title":"Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the collaborative ocular melanoma study (COMS): COMS report No. 15","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajoc.2022.101607_bib7","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/bjo.65.12.846","article-title":"Local recurrence of choroidal malignant melanoma following enucleation","volume":"65","author":"Sanke","year":"1981","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101607_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00004397-196206000-00006","article-title":"Extrascleral extension and orbital recurrence of malignant melanomas of the choroid and ciliary body","volume":"2","author":"Starr","year":"1962","journal-title":"Int Ophthalmol Clin"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101607_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/archopht.1966.03850010081016","article-title":"Recurrence of malignant melanoma in an orbit after 28 years","volume":"76","author":"Allen","year":"1966","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101607_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/01676839209087672","article-title":"Enlargement of the bony orbit by orbital recurrence of choroidal melanoma 21 years after enucleation","volume":"11","author":"Simonsz","year":"1992","journal-title":"Orbit"},{"issue":"11","key":"10.1016\/j.ajoc.2022.101607_bib11","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1001\/archopht.1977.04450110096010","article-title":"Orbital extension of choroidal and ciliary body melanomas","volume":"95","author":"Shammas","year":"1977","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101607_bib12","article-title":"Very late orbital recurrence of choroidal melanoma four decades post enucleation","volume":"11","author":"Menicacci","year":"2021","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101607_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ophtha.2015.09.014","article-title":"Local recurrence significantly increases the risk of metastatic uveal melanoma","volume":"123","year":"2016","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101607_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0161-6420(01)00902-2","article-title":"Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations","volume":"109","author":"Shields","year":"2002","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajoc.2022.101607_bib15","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjophthalmol-2012-302490","article-title":"Local treatment failure after globe-conserving therapy for choroidal melanoma","volume":"97","author":"Chang","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"23","key":"10.1016\/j.ajoc.2022.101607_bib16","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajoc.2022.101607_bib17","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.07918","article-title":"Cancer-associated TERT promoter mutations abrogate telomerase silencing. de Lange T","volume":"4","author":"Chiba","year":"2015","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101607_bib18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/bjc.2013.312","article-title":"TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours","volume":"109","author":"Griewank","year":"2013","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.ajoc.2022.101607_bib19","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1167\/iovs.14-14901","article-title":"Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions","volume":"55","author":"Koopmans","year":"2014","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.ajoc.2022.101607_bib20","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.3390\/ijms22115784","article-title":"Molecular genetics of conjunctival melanoma and prognostic value of TERT promoter mutation analysis","volume":"22","author":"van Poppelen","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ajoc.2022.101607_bib21","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/bjc.2013.804","article-title":"Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma","volume":"110","author":"Dono","year":"2014","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.ajoc.2022.101607_bib22","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa1310523","article-title":"A pilot study of the telomerase inhibitor Imetelstat for myelofibrosis","volume":"373","author":"Tefferi","year":"2015","journal-title":"N Engl J Med"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245199362200353X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245199362200353X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:03:02Z","timestamp":1762527782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S245199362200353X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":22,"alternative-id":["S245199362200353X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101607","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local recurrence of uveal melanoma and concomitant brain metastases associated with an activating telomerase promoter mutation seven years after secondary enucleation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101607","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101607"}}